Cryptosporidium parvum is a gastrointestinal parasite that can cause moderate to severe diarrhea in children and adults, and deadly opportunistic infection in AIDS patients. Because C. parvum is resistant to chlorine disinfectant treatment, it frequently causes water-borne outbreaks around the world. A study published on Nov. 12th in PLOS Pathogens provides a detailed analysis of a C. parvum protein that is central to glycolysis -- the only pathway by which the parasite can generate energy -- and identifies it as a potential drug target.
Guan Zhu and colleagues, from Texas A&M University in College Station, USA, study the parasite's metabolism during its complicated life-cycle. C. parvum exists both in free stages (where parasites are in the environment or in the host's digestive tract) and intracellular stages following host cell invasion, during which the parasite occupies a specialized compartment -- the parasitophorous vacuole -- which is delineated by a host-cell derived border called the parasitophorous vacuole membrane (PVM).
For this study, the researchers focused on lactate dehydrogenase (LDH), an enzyme central to glycolysis. Glycolysis is the only metabolic process by which organisms like C. parvum -- that lack functional mitochondria to derive energy from oxygen -- can generate ATP, the universal biological energy storage molecule. They found that the C. parvum LDH (CpLDH) protein is found inside the parasite's cells during the free stages, but is then transferred to the PVM during intracellular development, indicating involvement of the PVM in parasite energy metabolism, and specifically, in lactate fermentation. They also demonstrate that two known LDH inhibitors, gossypol and FX11, can inhibit both CpLDH activity and parasite growth.
The researchers summarize that their observations "not only reveal a new function for the poorly understood PVM structure in hosting the intracellular development of C. parvum, but also suggest LDH as a potential target for developing therapeutics against this opportunistic pathogen, for which fully effective treatments are not yet available". Acknowledging that the ultimate validation of CpLDH as a drug target requires tools for knockout or knockdown of genes of interest in Cryptosporidium, they say recent advances towards this goal raise hope that such validation will be possible in the near future.
Overall, they conclude that "the present data, together with the fact that C. parvum relies on glycolysis for producing ATP, support the notion that CpLDH is worth exploring as a potential target for the development of anti-cryptosporidial therapeutics".
Please use this URL to provide readers access to the paper (Link goes live upon article publication):
Press-Only Preview Of The Article:
Related Image for Press Use: https://www.plos.org/wp-content/uploads/2013/05/press-image.jpg
CpLDH on the parasitophorous vacuole membrane
Lactate dehydrogenase (LDH) is typically a cytosolic protein, which is true in the extracellular stages of the apicomplexan parasite Cryptosporidum parvum (oocysts and sporozoites). However, LDH becomes localized to the parasitophorous vacuole membrane (PVM) during the parasite intracellular development (LDH in red and nuclei in blue). The top panel show oocysts stained only for oocyst walls (green) and nuclei (blue).
Authors and Affiliations:
Haili Zhang, Texas A&M University, USA
Fengguang Guo, Texas A&M University, USA
Guan Zhu, Texas A&M University, USA
Please contact firstname.lastname@example.org if you would like more information.
Funding: This study was supported in part by the National Institute of Food and Agriculture (NIFA), United States Department of Agriculture (USDA) (http://www.nifa.usda.gov) (project numbers TEX09529 and TEX09591 to GZ), and the Western Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (WRCE) supported by grant number U54 AI057156 from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) (http://www.utmb.edu/cbeid/) (subaward to GZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
Citation: Zhang H, Guo F, Zhu G (2015) Cryptosporidium Lactate Dehydrogenase Is Associated with the Parasitophorous Vacuole Membrane and Is a Potential Target for Developing Therapeutics. PLoS Pathog 11(11): e1005250. doi:10.1371/journal.ppat.1005250